Skip to main content
Top
Published in: Neuroradiology 5/2007

01-05-2007 | Review

Idiopathic inflammatory-demyelinating diseases of the central nervous system

Authors: A. Rovira Cañellas, A. Rovira Gols, J. Río Izquierdo, M. Tintoré Subirana, X. Montalban Gairin

Published in: Neuroradiology | Issue 5/2007

Login to get access

Abstract

Idiopathic inflammatory-demyelinating diseases (IIDDs) include a broad spectrum of central nervous system disorders that can usually be differentiated on the basis of clinical, imaging, laboratory and pathological findings. However, there can be a considerable overlap between at least some of these disorders, leading to misdiagnoses or diagnostic uncertainty. The relapsing-remitting and secondary progressive forms of multiple sclerosis (MS) are the most common IIDDs. Other MS phenotypes include those with a progressive course from onset (primary progressive and progressive relapsing) or with a benign course continuing for years after onset (benign MS). Uncommon forms of IIDDs can be classified clinically into: (1) fulminant or acute IIDDs, such as the Marburg variant of MS, Baló’s concentric sclerosis, Schilder’s disease, and acute disseminated encephalomyelitis; (2) monosymptomatic IIDDs, such as those involving the spinal cord (transverse myelitis), optic nerve (optic neuritis) or brainstem and cerebellum; and (3) IIDDs with a restricted topographical distribution, including Devic’s neuromyelitis optica, recurrent optic neuritis and relapsing transverse myelitis. Other forms of IIDD, which are classified clinically and radiologically as pseudotumoral, can have different forms of presentation and clinical courses. Although some of these uncommon IIDDs are variants of MS, others probably correspond to different entities. MR imaging of the brain and spine is the imaging technique of choice for diagnosing these disorders, and together with the clinical and laboratory findings can accurately classify them. Precise classification of these disorders may have relevant prognostic and treatment implications, and might be helpful in distinguishing them from tumoral or infectious lesions, avoiding unnecessary aggressive diagnostic or therapeutic procedures.
Literature
1.
go back to reference Brinar VV (2004) Non-MS recurrent demyelinating diseases. Clin Neurol Neurosurg 106:197–210PubMed Brinar VV (2004) Non-MS recurrent demyelinating diseases. Clin Neurol Neurosurg 106:197–210PubMed
2.
go back to reference Fukazawa T, Kikuchi S, Niino M et al (2004) Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders. J Neurol Sci 225:71–78PubMed Fukazawa T, Kikuchi S, Niino M et al (2004) Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders. J Neurol Sci 225:71–78PubMed
3.
go back to reference Poser S, Luer W, Bruhn H, Frahm J, Bruck Y, Felgenhauer K (1992) Acute demyelinating disease. Classification and non-invasive diagnosis. Acta Neurol Scand 86:579–585PubMed Poser S, Luer W, Bruhn H, Frahm J, Bruck Y, Felgenhauer K (1992) Acute demyelinating disease. Classification and non-invasive diagnosis. Acta Neurol Scand 86:579–585PubMed
4.
go back to reference Charil A, Yousry TA, Rovaris M, Barkhof F, De Stefano N, Fazekas F et al (2006) MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol 5:841–852PubMed Charil A, Yousry TA, Rovaris M, Barkhof F, De Stefano N, Fazekas F et al (2006) MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol 5:841–852PubMed
5.
go back to reference Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907–911PubMed Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907–911PubMed
6.
go back to reference Hawkins SA, McDonnell GV (1999) Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 67:148–152PubMed Hawkins SA, McDonnell GV (1999) Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 67:148–152PubMed
7.
go back to reference Pittock SJ, Mayr WT, McClelland RL et al (2004) Disability profile of MS did not change over 10 years in a population-based prevalence cohort. Neurology 62:601–606PubMed Pittock SJ, Mayr WT, McClelland RL et al (2004) Disability profile of MS did not change over 10 years in a population-based prevalence cohort. Neurology 62:601–606PubMed
8.
go back to reference Pittock SJ, McClelland RL, Mayr WT (2004) Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 56:303–306PubMed Pittock SJ, McClelland RL, Mayr WT (2004) Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 56:303–306PubMed
9.
go back to reference Brex PA, Ciccarelli O, O’Riordan JI, Sailer M, Thompson AJ, Miller DH (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346:158–164PubMed Brex PA, Ciccarelli O, O’Riordan JI, Sailer M, Thompson AJ, Miller DH (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346:158–164PubMed
10.
go back to reference Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221–1231PubMed Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221–1231PubMed
11.
go back to reference Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717PubMed Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717PubMed
12.
go back to reference Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952PubMed Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952PubMed
13.
go back to reference Tintore M, Rovira A, Rio J, Nos C, Grive E, Tellez N et al (2005) Is optic neuritis more benign than other first attacks in multiple sclerosis? Ann Neurol 57:210–215PubMed Tintore M, Rovira A, Rio J, Nos C, Grive E, Tellez N et al (2005) Is optic neuritis more benign than other first attacks in multiple sclerosis? Ann Neurol 57:210–215PubMed
14.
go back to reference Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231PubMed Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231PubMed
15.
go back to reference McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121–127PubMed McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121–127PubMed
16.
go back to reference Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58:840–846PubMed Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58:840–846PubMed
17.
go back to reference Ge Y (2006) Multiple sclerosis: the role of MR imaging. AJNR Am J Neuroradiol 27:1165–1176PubMed Ge Y (2006) Multiple sclerosis: the role of MR imaging. AJNR Am J Neuroradiol 27:1165–1176PubMed
18.
go back to reference Freedman MS, Blumhardt LD, Brochet B, Comi G, Noseworthy JH, Sandberg-Wollheim M et al (2002) International consensus statement on the use of disease-modifying agents in multiple sclerosis. Mult Scler 8:19–23PubMed Freedman MS, Blumhardt LD, Brochet B, Comi G, Noseworthy JH, Sandberg-Wollheim M et al (2002) International consensus statement on the use of disease-modifying agents in multiple sclerosis. Mult Scler 8:19–23PubMed
19.
go back to reference European Study Group on interferon beta-1b in secondary progressive MS (1998) Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. Lancet 352:1491–1497 European Study Group on interferon beta-1b in secondary progressive MS (1998) Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. Lancet 352:1491–1497
20.
go back to reference Calabresi PA (2002) Considerations in the treatment of relapsing-remitting multiple sclerosis. Neurology 58(8 Suppl 4):S10–S22PubMed Calabresi PA (2002) Considerations in the treatment of relapsing-remitting multiple sclerosis. Neurology 58(8 Suppl 4):S10–S22PubMed
21.
go back to reference Montalban X (2005) Primary progressive multiple sclerosis. Curr Opin Neurol 18:261–266PubMed Montalban X (2005) Primary progressive multiple sclerosis. Curr Opin Neurol 18:261–266PubMed
22.
go back to reference Stevenson VL, Miller DH, Rovaris M, Barkhof F, Brochet B, Dousset V et al (1999) Primary and transitional progressive MS: a clinical and MRI cross-sectional study. Neurology 52:839–845PubMed Stevenson VL, Miller DH, Rovaris M, Barkhof F, Brochet B, Dousset V et al (1999) Primary and transitional progressive MS: a clinical and MRI cross-sectional study. Neurology 52:839–845PubMed
23.
go back to reference Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH et al (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831–835PubMed Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH et al (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831–835PubMed
24.
go back to reference Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15:239–245PubMed Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15:239–245PubMed
25.
go back to reference Leary SM, Miller DH, Stevenson VL, Brex PA, Chard DT, Thompson AJ (2003) Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial. Neurology 60:44–51PubMed Leary SM, Miller DH, Stevenson VL, Brex PA, Chard DT, Thompson AJ (2003) Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial. Neurology 60:44–51PubMed
26.
go back to reference Johnson MD, Lavin P, Whetsell WO Jr (1990) Fulminant monophasic multiple sclerosis, Marburg’s type. J Neurol Neurosurg Psychiatry 53:918–921PubMed Johnson MD, Lavin P, Whetsell WO Jr (1990) Fulminant monophasic multiple sclerosis, Marburg’s type. J Neurol Neurosurg Psychiatry 53:918–921PubMed
27.
go back to reference Bitsch A, Wegener C, da Costa C, Bunkowski S, Reimers CD, Prange HW, Bruck W (1999) Lesion development in Marburg’s type of acute multiple sclerosis: from inflammation to demyelination. Mult Scler 5:138–146PubMed Bitsch A, Wegener C, da Costa C, Bunkowski S, Reimers CD, Prange HW, Bruck W (1999) Lesion development in Marburg’s type of acute multiple sclerosis: from inflammation to demyelination. Mult Scler 5:138–146PubMed
28.
go back to reference Capello E, Mancardi GL (2004) Marburg type and Balo’s concentric sclerosis: rare and acute variants of multiple sclerosis. Neurol Sci 25 (Suppl 4):S361–S363PubMed Capello E, Mancardi GL (2004) Marburg type and Balo’s concentric sclerosis: rare and acute variants of multiple sclerosis. Neurol Sci 25 (Suppl 4):S361–S363PubMed
29.
go back to reference Rodriguez M, Karnes WE, Bartleson JD, Pineda AA (1993) Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology 43:1100–1104PubMed Rodriguez M, Karnes WE, Bartleson JD, Pineda AA (1993) Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology 43:1100–1104PubMed
30.
go back to reference Weinshenker BG, O’Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW et al (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878–886PubMed Weinshenker BG, O’Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW et al (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878–886PubMed
31.
go back to reference Jeffery DR, Lefkowitz DS, Crittenden JP (2004) Treatment of Marburg variant multiple sclerosis with mitoxantrone. J Neuroimaging 14:58–62PubMed Jeffery DR, Lefkowitz DS, Crittenden JP (2004) Treatment of Marburg variant multiple sclerosis with mitoxantrone. J Neuroimaging 14:58–62PubMed
32.
go back to reference Lhermitte F, Escourolle R, Hauw JJ, Gray F, Serdaru M, Lyon-Caen O (1981) Necrotic aspects of multiple sclerosis and Schilder’s disease. Rev Neurol (Paris) 137:589–600 Lhermitte F, Escourolle R, Hauw JJ, Gray F, Serdaru M, Lyon-Caen O (1981) Necrotic aspects of multiple sclerosis and Schilder’s disease. Rev Neurol (Paris) 137:589–600
33.
go back to reference Garell PC, Menezes AH, Baumbach G et al (1998) Presentation, management and follow-up of Schilder’s disease. Pediatr Neurosurg 29:86–91PubMed Garell PC, Menezes AH, Baumbach G et al (1998) Presentation, management and follow-up of Schilder’s disease. Pediatr Neurosurg 29:86–91PubMed
34.
go back to reference Mehler MF, Rabinowich L (1989) Inflammatory myelinoclastic diffuse sclerosis (Schilder’s disease): neuroradiologic findings. AJNR Am J Neuroradiol 10:176–180PubMed Mehler MF, Rabinowich L (1989) Inflammatory myelinoclastic diffuse sclerosis (Schilder’s disease): neuroradiologic findings. AJNR Am J Neuroradiol 10:176–180PubMed
35.
go back to reference Sastre-Garriga J, Rovira A, Rio J, Tintore M, Grive E, Montalban X (2003) Clinically definite multiple sclerosis after radiological Schilder-like onset. J Neurol 250:871–873PubMed Sastre-Garriga J, Rovira A, Rio J, Tintore M, Grive E, Montalban X (2003) Clinically definite multiple sclerosis after radiological Schilder-like onset. J Neurol 250:871–873PubMed
36.
go back to reference Dresser LP, Tourian AY, Anthony DC (1991) A case of myelinoclastic diffuse sclerosis in an adult. Neurology 41:316–318PubMed Dresser LP, Tourian AY, Anthony DC (1991) A case of myelinoclastic diffuse sclerosis in an adult. Neurology 41:316–318PubMed
37.
go back to reference Eblen F, Poremba M, Grodd W, Opitz H, Roggendorf W, Dichgans J (1991) Myelinoclastic diffuse sclerosis (Schilder’s disease): cliniconeuroradiologic correlations. Neurology 41:589–591PubMed Eblen F, Poremba M, Grodd W, Opitz H, Roggendorf W, Dichgans J (1991) Myelinoclastic diffuse sclerosis (Schilder’s disease): cliniconeuroradiologic correlations. Neurology 41:589–591PubMed
38.
go back to reference Pretorius ML, Loock DB, Ravenscroft A, Schoeman JF (1998) Demyelinating disease of Schilder type in three young South African children: dramatic response to corticosteroids. J Child Neurol 13:197–201PubMedCrossRef Pretorius ML, Loock DB, Ravenscroft A, Schoeman JF (1998) Demyelinating disease of Schilder type in three young South African children: dramatic response to corticosteroids. J Child Neurol 13:197–201PubMedCrossRef
39.
go back to reference Yao DL, Webster HD, Hudson LD, Brenner M, Liu DS, Escobar AI et al (1994) Concentric sclerosis (Balo): morphometric and in situ hybridization study of lesions in six patients. Ann Neurol 35:18–30PubMed Yao DL, Webster HD, Hudson LD, Brenner M, Liu DS, Escobar AI et al (1994) Concentric sclerosis (Balo): morphometric and in situ hybridization study of lesions in six patients. Ann Neurol 35:18–30PubMed
40.
go back to reference Gharagozloo AM, Poe LB, Collins GH (1994) Antemortem diagnosis of Balo concentric sclerosis: correlative MR imaging and pathologic features. Radiology 191:817–819PubMed Gharagozloo AM, Poe LB, Collins GH (1994) Antemortem diagnosis of Balo concentric sclerosis: correlative MR imaging and pathologic features. Radiology 191:817–819PubMed
41.
go back to reference Stadelmann C, Ludwin S, Tabira T, Guseo A, Luchinetti CF, Leel-Ossy L et al (2005) Tissue preconditioning may explain concentric lesions in Baló’s type of multiple sclerosis. Brain 128:979–987PubMed Stadelmann C, Ludwin S, Tabira T, Guseo A, Luchinetti CF, Leel-Ossy L et al (2005) Tissue preconditioning may explain concentric lesions in Baló’s type of multiple sclerosis. Brain 128:979–987PubMed
42.
go back to reference Korte JH, Bom EP, Vos LD, Breuer TJ, Wondergem JH (1994) Balo concentric sclerosis: MR diagnosis. AJNR Am J Neuroradiol 15:1284–1285PubMed Korte JH, Bom EP, Vos LD, Breuer TJ, Wondergem JH (1994) Balo concentric sclerosis: MR diagnosis. AJNR Am J Neuroradiol 15:1284–1285PubMed
43.
go back to reference Wiendl H, Weissert R, Herrlinger U, Krapf H, Kuker W (2005) Diffusion abnormality in Balo’s concentric sclerosis: clues for the pathogenesis. Eur Neurol 53:42–44PubMed Wiendl H, Weissert R, Herrlinger U, Krapf H, Kuker W (2005) Diffusion abnormality in Balo’s concentric sclerosis: clues for the pathogenesis. Eur Neurol 53:42–44PubMed
44.
go back to reference Menge T, Hemmer B, Nessler S, Wiendl H, Neuhaus O, Hartung HP et al (2005) Acute disseminated encephalomyelitis: an update. Arch Neurol 62:1673–1680PubMed Menge T, Hemmer B, Nessler S, Wiendl H, Neuhaus O, Hartung HP et al (2005) Acute disseminated encephalomyelitis: an update. Arch Neurol 62:1673–1680PubMed
45.
go back to reference Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG (2000) Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 123:2407–2422PubMed Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG (2000) Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 123:2407–2422PubMed
46.
go back to reference Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ (2001) Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 56:1308–1312PubMed Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ (2001) Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 56:1308–1312PubMed
47.
go back to reference Tenembaum S, Chamoles N, Fejerman N (2002) Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 59:1224–1231PubMed Tenembaum S, Chamoles N, Fejerman N (2002) Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 59:1224–1231PubMed
48.
go back to reference Dale RC, Branson JA (2005) Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis? Arch Dis Child 90:636–639PubMed Dale RC, Branson JA (2005) Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis? Arch Dis Child 90:636–639PubMed
49.
go back to reference Caldemeyer KS, Smith RR, Harris TM, Edwards MK (1994) MRI in acute disseminated encephalomyelitis. Neuroradiology 36:216–220PubMed Caldemeyer KS, Smith RR, Harris TM, Edwards MK (1994) MRI in acute disseminated encephalomyelitis. Neuroradiology 36:216–220PubMed
50.
go back to reference Kesselring J, Miller DH, Robb SA, Kendall BE, Moseley IF, Kingsley D et al (1990) Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain 113:291–302PubMed Kesselring J, Miller DH, Robb SA, Kendall BE, Moseley IF, Kingsley D et al (1990) Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain 113:291–302PubMed
51.
go back to reference O’Riordan JI, Gomez-Anson B, Moseley IF, Miller DH (1999) Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease. J Neurol Sci 167:132–136PubMed O’Riordan JI, Gomez-Anson B, Moseley IF, Miller DH (1999) Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease. J Neurol Sci 167:132–136PubMed
52.
go back to reference Honkaniemi J, Dastidar P, Kahara V, Haapasalo H (2001) Delayed MR imaging changes in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 22:1117–1124PubMed Honkaniemi J, Dastidar P, Kahara V, Haapasalo H (2001) Delayed MR imaging changes in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 22:1117–1124PubMed
53.
go back to reference Mikaeloff Y, Adamsbaum C, Husson B, Vallee L, Ponsot G, Confavreux C et al (2004) MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 127:1942–1947PubMed Mikaeloff Y, Adamsbaum C, Husson B, Vallee L, Ponsot G, Confavreux C et al (2004) MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 127:1942–1947PubMed
54.
go back to reference Krupp L, MacAllister W; on behalf of the International Pediatric MS Study Group (2006) Consensus definitions of acquired CNS demyelinating disorders of childhood. Mult Scler 16 [Suppl 1]:S23 Krupp L, MacAllister W; on behalf of the International Pediatric MS Study Group (2006) Consensus definitions of acquired CNS demyelinating disorders of childhood. Mult Scler 16 [Suppl 1]:S23
55.
go back to reference Hartung HP, Grossman RI (2001) ADEM: distinct disease or part of the MS spectrum? Neurology 56:1257–1260PubMed Hartung HP, Grossman RI (2001) ADEM: distinct disease or part of the MS spectrum? Neurology 56:1257–1260PubMed
56.
go back to reference Shahar E, Andraus J, Savitzki D, Pilar G, Zelnik N (2002) Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins. J Child Neurol 17:810–814PubMed Shahar E, Andraus J, Savitzki D, Pilar G, Zelnik N (2002) Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins. J Child Neurol 17:810–814PubMed
57.
go back to reference Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58:143–146PubMed Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58:143–146PubMed
58.
go back to reference Marchioni E, Marinou-Aktipi K, Uggetti C, Bottanelli M, Pichiecchio A, Soragna D et al (2002) Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 249:100–104PubMed Marchioni E, Marinou-Aktipi K, Uggetti C, Bottanelli M, Pichiecchio A, Soragna D et al (2002) Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 249:100–104PubMed
59.
go back to reference Apak RA, Anlar B, Saatci I (1999) A case of relapsing acute disseminated encephalomyelitis with high dose corticosteroid treatment. Brain Dev 21:279–282PubMed Apak RA, Anlar B, Saatci I (1999) A case of relapsing acute disseminated encephalomyelitis with high dose corticosteroid treatment. Brain Dev 21:279–282PubMed
60.
go back to reference Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B (2001) Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 56:1313–1318PubMed Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B (2001) Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 56:1313–1318PubMed
61.
go back to reference Gibbs WN, Kreidie MA, Kim RC, Hasso AN (2005) Acute hemorrhagic leukoencephalitis: neuroimaging features and neuropathologic diagnosis. J Comput Assist Tomogr 29:689–693PubMed Gibbs WN, Kreidie MA, Kim RC, Hasso AN (2005) Acute hemorrhagic leukoencephalitis: neuroimaging features and neuropathologic diagnosis. J Comput Assist Tomogr 29:689–693PubMed
62.
go back to reference Zagzag D, Miller DC, Kleinman GM, Abati A, Donnenfeld H, Budzilovich GN (1993) Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis. Am J Surg Pathol 17:537–545PubMed Zagzag D, Miller DC, Kleinman GM, Abati A, Donnenfeld H, Budzilovich GN (1993) Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis. Am J Surg Pathol 17:537–545PubMed
63.
go back to reference Kepes JJ (1993) Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 33:18–27PubMed Kepes JJ (1993) Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 33:18–27PubMed
64.
go back to reference Dagher AP, Smirniotopoulos J (1996) Tumefactive demyelinating lesions. Neuroradiology 38:560–565PubMed Dagher AP, Smirniotopoulos J (1996) Tumefactive demyelinating lesions. Neuroradiology 38:560–565PubMed
65.
go back to reference Given CA, Stevens BS, Lee C (2004) The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol 182:195–199PubMed Given CA, Stevens BS, Lee C (2004) The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol 182:195–199PubMed
66.
go back to reference Cucurella MG, Rovira A, Grivé E, Tintoré M, Montalban X, Alonso J (2002) Serial proton spectroscopy, magnetization transfer ratio and T2 relaxation in pseudotumoral demyelinating lesions. NMR Biomed 15:284–292PubMed Cucurella MG, Rovira A, Grivé E, Tintoré M, Montalban X, Alonso J (2002) Serial proton spectroscopy, magnetization transfer ratio and T2 relaxation in pseudotumoral demyelinating lesions. NMR Biomed 15:284–292PubMed
67.
go back to reference Masdeu JC, Quinto C, Olivera C, Tenner M, Leslie D, Visintainer P (2000) Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 54:1427–1433PubMed Masdeu JC, Quinto C, Olivera C, Tenner M, Leslie D, Visintainer P (2000) Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 54:1427–1433PubMed
68.
go back to reference Schwartz KM, Erickson BJ, Lucchinetti C (2006) Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology. Neuroradiology 48:143–149PubMed Schwartz KM, Erickson BJ, Lucchinetti C (2006) Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology. Neuroradiology 48:143–149PubMed
69.
go back to reference Law M, Meltzer DE, Cha S (2002) Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion. Neuroradiology 44:986–989PubMed Law M, Meltzer DE, Cha S (2002) Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion. Neuroradiology 44:986–989PubMed
70.
go back to reference Butteriss DJ, Ismail A, Ellison DW, Birchall D (2003) Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol 76:662–665PubMed Butteriss DJ, Ismail A, Ellison DW, Birchall D (2003) Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol 76:662–665PubMed
71.
go back to reference De Stefano N, Caramanos Z, Preul MC, Francis G, Antel JP, Arnold DL (1998) In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol 44:273–278PubMed De Stefano N, Caramanos Z, Preul MC, Francis G, Antel JP, Arnold DL (1998) In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol 44:273–278PubMed
72.
go back to reference Mao-Draayer Y, Braff S, Pendlebury W, Panitch H (2002) Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology 59:1074–1077PubMed Mao-Draayer Y, Braff S, Pendlebury W, Panitch H (2002) Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology 59:1074–1077PubMed
73.
go back to reference Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53:1107–1114PubMed Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53:1107–1114PubMed
74.
go back to reference Beck RW, Trobe JD, Moke PS, Gal RL, Xing D, Bhatti MT et al (2003) High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 121:944–949PubMed Beck RW, Trobe JD, Moke PS, Gal RL, Xing D, Bhatti MT et al (2003) High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 121:944–949PubMed
75.
go back to reference Rocca MA, Hickman SJ, Bö L, Agosta F, Miller DH, Comi G et al (2005) Imaging the optic nerve in multiple sclerosis. Mult Scler 11:537–541PubMed Rocca MA, Hickman SJ, Bö L, Agosta F, Miller DH, Comi G et al (2005) Imaging the optic nerve in multiple sclerosis. Mult Scler 11:537–541PubMed
76.
go back to reference Gass A, Moseley IF, Barker GJ, Jones S, MacManus D, McDonald WI, Miller DH (1996) Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI. Neuroradiology 38:317–321PubMed Gass A, Moseley IF, Barker GJ, Jones S, MacManus D, McDonald WI, Miller DH (1996) Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI. Neuroradiology 38:317–321PubMed
77.
go back to reference Hickman SJ, Miszkiel KA, Plant GT, Miller DH (2005) The optic nerve sheath on MRI in acute optic neuritis. Neuroradiology 47:51–55PubMed Hickman SJ, Miszkiel KA, Plant GT, Miller DH (2005) The optic nerve sheath on MRI in acute optic neuritis. Neuroradiology 47:51–55PubMed
78.
go back to reference Kupersmith MJ, Alban T, Zeiffer B, Lefton D (2002) Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain 125:812–822PubMed Kupersmith MJ, Alban T, Zeiffer B, Lefton D (2002) Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain 125:812–822PubMed
79.
go back to reference Davies MB, Williams R, Haq N, Pelosi L, Hawkins CP (1998) MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis. Neuroradiology 40:765–770PubMed Davies MB, Williams R, Haq N, Pelosi L, Hawkins CP (1998) MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis. Neuroradiology 40:765–770PubMed
80.
go back to reference Miller DH, Ormerod IE, Rudge P, Kendall BE, Moseley IF, McDonald WI (1989) The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol 26:635–639PubMed Miller DH, Ormerod IE, Rudge P, Kendall BE, Moseley IF, McDonald WI (1989) The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol 26:635–639PubMed
81.
go back to reference Sastre-Garriga J, Tintore M, Rovira A, Grive E, Pericot I, Comabella M et al (2003) Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. Mult Scler 9:39–43PubMed Sastre-Garriga J, Tintore M, Rovira A, Grive E, Pericot I, Comabella M et al (2003) Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. Mult Scler 9:39–43PubMed
82.
go back to reference Bickerstaff ER, Cloake PC (1951) Mesencephalitis and rhombencephalitis. Br Med J 4723:77–81 Bickerstaff ER, Cloake PC (1951) Mesencephalitis and rhombencephalitis. Br Med J 4723:77–81
83.
go back to reference Yaqub BA, al-Deeb SM, Daif AK, Sharif HS, Shamena AR, al-Jaberi M et al (1990) Bickerstaff brainstem encephalitis. A grave non-demyelinating disease with benign prognosis. J Neurol Sci 96:29–40PubMed Yaqub BA, al-Deeb SM, Daif AK, Sharif HS, Shamena AR, al-Jaberi M et al (1990) Bickerstaff brainstem encephalitis. A grave non-demyelinating disease with benign prognosis. J Neurol Sci 96:29–40PubMed
84.
go back to reference Stevenson VL, Ferguson SM, Bain PG (2003) Bickerstaff’s brainstem encephalitis, Miller Fisher syndrome and Guillain-Barre syndrome overlap with negative anti-GQ1b antibodies. Eur J Neurol 10:187PubMed Stevenson VL, Ferguson SM, Bain PG (2003) Bickerstaff’s brainstem encephalitis, Miller Fisher syndrome and Guillain-Barre syndrome overlap with negative anti-GQ1b antibodies. Eur J Neurol 10:187PubMed
85.
go back to reference Winer JB (2001) Bickerstaff’s encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 71:433–435PubMed Winer JB (2001) Bickerstaff’s encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 71:433–435PubMed
86.
go back to reference Mondejar RR, Santos JM, Villalba EF (2002) MRI findings in a remitting-relapsing case of Bickerstaff encephalitis. Neuroradiology 44:411–414PubMed Mondejar RR, Santos JM, Villalba EF (2002) MRI findings in a remitting-relapsing case of Bickerstaff encephalitis. Neuroradiology 44:411–414PubMed
87.
go back to reference Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499–505 Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499–505
88.
go back to reference Lycklama G, Thompson A, Filippi M, Miller D, Polman C, Fazekas F et al (2003) Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2:555–562PubMed Lycklama G, Thompson A, Filippi M, Miller D, Polman C, Fazekas F et al (2003) Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2:555–562PubMed
89.
go back to reference Dietemann JL, Thibaut-Menard A, Warter JM, Neugroschl C, Tranchant C, Gillis C, Eid MA, Bogorin A (2000) MRI in multiple sclerosis of the spinal cord: evaluation of fast short-tau inversion-recovery and spin-echo sequences. Neuroradiology 42:810–813PubMed Dietemann JL, Thibaut-Menard A, Warter JM, Neugroschl C, Tranchant C, Gillis C, Eid MA, Bogorin A (2000) MRI in multiple sclerosis of the spinal cord: evaluation of fast short-tau inversion-recovery and spin-echo sequences. Neuroradiology 42:810–813PubMed
90.
go back to reference Campi A, Pontesilli S, Gerevini S, Scotti G (2000) Comparison of MRI pulse sequences for investigation of lesions of the cervical spinal cord. Neuroradiology 42:669–675PubMed Campi A, Pontesilli S, Gerevini S, Scotti G (2000) Comparison of MRI pulse sequences for investigation of lesions of the cervical spinal cord. Neuroradiology 42:669–675PubMed
91.
go back to reference Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E et al (2004) Clinical characteristics, course and prognosis of relapsing Devic’s neuromyelitis optica. J Neurol 251:47–52PubMed Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E et al (2004) Clinical characteristics, course and prognosis of relapsing Devic’s neuromyelitis optica. J Neurol 251:47–52PubMed
92.
93.
go back to reference Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112PubMed Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112PubMed
94.
go back to reference Filippi M, Rocca MA, Moiola L et al (1999) MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica. Neurology 53:1705–1710PubMed Filippi M, Rocca MA, Moiola L et al (1999) MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica. Neurology 53:1705–1710PubMed
95.
go back to reference Rocca MA, Agosta F, Mezzapesa DM et al (2004) Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology 62:476–478PubMed Rocca MA, Agosta F, Mezzapesa DM et al (2004) Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology 62:476–478PubMed
96.
go back to reference Mandler RN, Davis LE, Jeffery DR, Kornfeld M (1993) Devic’s neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34:162–168PubMed Mandler RN, Davis LE, Jeffery DR, Kornfeld M (1993) Devic’s neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34:162–168PubMed
97.
go back to reference O’Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ et al (1996) Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatry 60:382–387PubMedCrossRef O’Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ et al (1996) Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatry 60:382–387PubMedCrossRef
98.
go back to reference Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477PubMed Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477PubMed
99.
go back to reference Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF et al (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566–569PubMed Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF et al (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566–569PubMed
100.
go back to reference Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489PubMed Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489PubMed
101.
go back to reference Wingerchuk DM, Weinshenker BG (2005) Neuromyelitis optica. Curr Treat Options Neurol 7:173–182PubMed Wingerchuk DM, Weinshenker BG (2005) Neuromyelitis optica. Curr Treat Options Neurol 7:173–182PubMed
102.
go back to reference Mandler RN, Ahmed W, Dencoff JE (1998) Devic’s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 51:1219–1220PubMed Mandler RN, Ahmed W, Dencoff JE (1998) Devic’s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 51:1219–1220PubMed
103.
go back to reference Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270–1272PubMed Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270–1272PubMed
104.
go back to reference Lucchinetti CF, Kiers L, O’Duffy A, Gomez MR, Cross S, Leavitt JA et al (1997) Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 49:1413–1418PubMed Lucchinetti CF, Kiers L, O’Duffy A, Gomez MR, Cross S, Leavitt JA et al (1997) Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 49:1413–1418PubMed
105.
go back to reference Pirko I, Blauwet LK, Lesnick TG, Weinshenker BG (2004) The natural history of recurrent optic neuritis. Arch Neurol 61:1401–1405PubMed Pirko I, Blauwet LK, Lesnick TG, Weinshenker BG (2004) The natural history of recurrent optic neuritis. Arch Neurol 61:1401–1405PubMed
106.
go back to reference Wingerchuk DM, Weinshenker BG (2003) Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 60:848–853PubMed Wingerchuk DM, Weinshenker BG (2003) Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 60:848–853PubMed
107.
go back to reference Kim KK (2003) Idiopathic recurrent transverse myelitis. Arch Neurol 60:1290–1294PubMed Kim KK (2003) Idiopathic recurrent transverse myelitis. Arch Neurol 60:1290–1294PubMed
108.
go back to reference Chan KH, Tsang KL, Fong GC, Cheung RT, Ho SL (2005) Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica. Clin Neurol Neurosurg 107:132–135PubMed Chan KH, Tsang KL, Fong GC, Cheung RT, Ho SL (2005) Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica. Clin Neurol Neurosurg 107:132–135PubMed
109.
go back to reference Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, Eisen KA, Purves SJ, Low MD, Brandejs V et al (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180–185PubMed Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, Eisen KA, Purves SJ, Low MD, Brandejs V et al (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180–185PubMed
Metadata
Title
Idiopathic inflammatory-demyelinating diseases of the central nervous system
Authors
A. Rovira Cañellas
A. Rovira Gols
J. Río Izquierdo
M. Tintoré Subirana
X. Montalban Gairin
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Neuroradiology / Issue 5/2007
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-007-0216-2

Other articles of this Issue 5/2007

Neuroradiology 5/2007 Go to the issue